FdaApplication
BLA 125472
Identifiers
- fda_app_no: BLA125472
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2013-10-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACTEMRA | TOCILIZUMAB | 162MG/0.9ML | Injection |
| ACTEMRA | — | 162MG/0.9ML | Injection |
2 products